XML 79 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Business Segment Information

The Company's business segment information was as follows (in thousands):

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

 

2022

 

Proteomics segment:

 

 

 

 

 

 

 

 

Revenue

$

135,789

 

 

$

63,883

 

 

$

52,502

 

Cost of revenue

 

73,992

 

 

 

37,644

 

 

 

32,461

 

Operating expenses

 

123,692

 

 

 

47,647

 

 

 

47,429

 

Proteomics loss from operations

$

(61,895

)

 

$

(21,408

)

 

$

(27,388

)

 

 

 

 

 

 

 

 

 

Genomics segment:

 

 

 

 

 

 

 

 

Revenue

$

38,643

 

 

$

42,457

 

 

$

45,446

 

Cost of revenue:

 

16,178

 

 

 

18,246

 

 

 

28,436

 

Operating expenses

 

19,267

 

 

 

24,317

 

 

 

42,622

 

Genomics income (loss) from operations

$

3,198

 

 

$

(106

)

 

$

(25,612

)

Total segment loss from operations

$

(58,697

)

 

$

(21,514

)

 

$

(53,000

)

 

 

 

 

 

 

 

 

 

Reconciliation of income (loss) from operations:

 

 

 

 

 

 

 

 

Corporate expenses

 

76,060

 

 

 

41,525

 

 

 

49,616

 

Restructuring and related charges

 

12,500

 

 

 

7,076

 

 

 

9,732

 

Transaction and integration expenses

 

27,979

 

 

 

6,485

 

 

 

3,857

 

Total loss from operations

$

(175,236

)

 

$

(76,600

)

 

$

(116,205

)

 

 

 

 

 

 

 

 

 

Depreciation and amortization:

 

 

 

 

 

 

 

 

Proteomics

$

9,198

 

 

$

12,072

 

 

$

12,223

 

Genomics

 

1,486

 

 

 

601

 

 

 

230